Why the study?
Do fenofibrate and telmisartan limit abdominal aortic aneurysm growth in patients with AAA?
Population
Patients with abdominal aortic aneurysm (AAA)
Design
Review
Authors
Loading...
Fenofibrate and telmisartan show preclinical promise for limiting AAA growth, prompting ongoing randomized controlled trials.
Do fenofibrate and telmisartan limit abdominal aortic aneurysm growth in patients with AAA?
Fenofibrate and telmisartan show preclinical promise for limiting AAA growth, prompting ongoing randomized controlled trials.
Rowbotham et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: